Feature | July 15, 2007| Jeanne-Marie Philips and Steven Washer

Will the DRA Deplete Cardiologists’ Assets?

Is the DRA a catalyst for depleting assets or driving efficiency?

In October, they gave us fair warning: “If the Deficit Reduction Act goes through…facilities will buy less and less expensive products,” said one participant. Others echoed this, and now the river of anxiety has morphed into a tsunami.
With the DRA here, we re-visit the issue, questioning an industry cross-section to find some surprising issues hiding in the shadows.
How has your organization adapted to prepare for the DRA?
Peter Rothschild, M.D. president, Patient Comfort Systems: Despite a bad situation, the imaging centers that will win will be those taking a long-term view and continuing to improve services and patient satisfaction to increase market share.
Nancy Gillen, VP MR, Siemens Medical Solutions: Part of our charter is to continue focusing on decreasing costs and working closely with customers to introduce innovations that are clinically focused and have benefits in capital and operational dollars and efficiency. In MRI, we are focusing on efficiency and workflow that ultimately allows imaging of more patients in shorter time periods.
Alan D. Kaye, M.D., president, Advanced Radiology Consultants, chairman, Department of Radiology, Bridgeport Hospital, Bridgeport, CT: We began planning almost immediately upon DRA passage. Each director (IT, HR, operations, marketing, and finance) was charged with analyzing areas for enhanced efficiency and productivity in their area and for finding opportunities for enhancing revenue. We achieved significant savings, but also came to realize that to compensate for DRA losses, we must supplement cost-cutting with new revenue sources.
Murray A. Reicher, M.D., Co-CEO, Imaging Healthcare Specialists LLC, chairman, DR Systems Inc.: Every radiology organization is trying to adapt by renegotiating their private contracts, by dropping the Medicare/HOPPS fee schedule wherever possible, and by cutting costs. However, “adaptation” implies an evolutionary process. The DRA is not evolutionary; it’s a draconian cut that ironically most hurts independent outpatient centers, where radiology costs have historically been lowest. The DRA will lead to imaging center bankruptcies, with the unintended consequences of driving outpatients to more costly hospitals, or self-referred imaging facilities.
Bob Cooke, VP, Network Business Management, FUJIFILM Medical Systems USA Inc.: We have developed pricing models and financing tools to help facilitate acquisition of critical digital imaging modalities and infrastructure. We have also developed a full suite of managed PACS services, allowing customers to benefit from economies of scale.
2 How has the DRA affected your imaging
product introductions?
Roth: Imaging centers will be keeping their MRI equipment significantly longer, and accessories such as pads will wear out. Tears are serious issues, making pads impossible to thoroughly clean and putting patients and technologists at risk. This will increase demand for our MRI pad products.
Gillen: Our long-term strategy is developing products that deliver a cost/productivity customer advantage. We have always considered this type of trend, so it has not had a negative but a positive impact.
Kaye: Initially, we froze purchases of new and unplanned equipment. Now, we have slowed acquisition of new equipment and upgrades and not entered any new markets.
Reicher: All imaging providers are more cautious in purchasing this year. Paradoxically, the RIS/PACS technology my company DR Systems provides, which lowers operating costs, is now more essential than ever.
Cooke: There is no question that DRA will place financial pressure on certain providers. This may even stimulate demand for technology to help deliver a digital imaging service.
3 Will the DRA affect innovation and the practice
of medicine?
Roth: Significant reimbursement cuts create a definite slow down in innovation, and smaller players often disappear, decreasing product diversity. The silver lining may be that as MRI reimbursements decrease, utilization will increase and compensate.
Gillen: DRA may have a short-term effect, but ultimately medical efficacy drives medical services. For example, the recent recommendation by the American Cancer Society that annual breast MRIs should be done on women with high risk, family histories or dense tissue will dramatically impact patient treatment. We have to deal with the diseases in front of us today and to work towards a predictive and personal method of health care for tomorrow.
Kaye: Depends what you mean by “innovation.” There will be definite retardation of imaging technology introductions. Conversely, business innovations that drive efficiency will thrive for both vendors and providers.
Cooke: The immediate impact is an increased bottom line focus as providers face dramatic reimbursement cuts for outpatient exams. Compliance with emerging P4P programs is an obvious opportunity to improve margin.
4 How can manufacturers and purchasers work together to overcome the obstacles created by the DRA?
Roth: By developing relatively inexpensive products and increasing throughput as well as patient and clinician satisfaction. Imaging service demand is increasing at double-digit percentages. Combined with the aging population, high-quality imaging volume will overcome much of the DRA cuts.
Gillen: Open dialog between manufacturers and purchasers is critical and helps determine which product is right for the customer.
Kaye: Manufacturers must abandon their practices of promoting self-referral of imaging by non-radiologists.
Cooke: Manufacturers must adapt products and value equations to ensure successful digital transformations.
Reicher: If public and private payors refuse to authorize or compensate self-referred scans, imaging costs will drop.
Clearly, some believe the remedy is going to bring on the very disease it was invented to cure. Others believe that the DRA may be partially successful — but not in the way intended, of course. The act of self-referring may cease, but only because clinics engaging in it go out of business. The big question remains: Will patients have more or less access to quality healthcare?

Jeanne-Marie Philips is the president of HealthFlash Marketing Communications, www. healthflashmarketing.com
Steven Washer is the president and CEO of MedView Media, LLC, www.medviewmedia.com

Related Content

Videos | Cardiac Imaging | September 10, 2018
Leslee Shaw, Ph.D., professor of cardiology and rad
Arterys collaborated with GE Healthcare to create the ViosWorks software to cardiac MRI analysis.

Arterys collaborated with GE Healthcare to create the ViosWorks software. The software integrates artificial intelligence to speed workflow and perform a full 3-D chest volume scan with myocardium motion, blood flow, time and fully automated quantification.

Feature | Cardiac Imaging | March 30, 2018 | Jeff Zagoudis
Magnetic resonance imaging (MRI) for cardiac assessment provides a radiation-free alternative to other commonly used
New Policy Decisions Give Millions Access to HeartFlow FFRct Analysis
News | Cardiac Imaging | February 01, 2018
February 1, 2018 – HeartFlow announced that seven new commercial payers issued positive medical policies covering the
Clear detail of the in-stent restenosis can be seen in this image from the new high-resolution Canon Precision CT system. RSNA 2017, #RSNA2017, #RSNA17

Clear detail of the in-stent restenosis can be seen in this image from the new high-resolution Canon Aquilion Precision CT system.

Feature | Cardiac Imaging | January 23, 2018 | Dave Fornell
Medical imaging plays a key role in cardiology, and most of the newest radiology technology advances are first unveil
Philips Introduces Technology Maximizer Program for Imaging Equipment Upgrades
Technology | Cardiac Imaging | January 17, 2018
Philips recently announced the launch of Technology Maximizer, a cross-modality program designed to boost the clinical...
Videos | Cardiac Imaging | December 29, 2017
ITN and DAIC Editor Dave Fornell takes a tour of some of the most interesting new medical imaging technologies on the
Siemens Healthineers Introduces Share360 Tailored Service Portfolio
News | Cardiac Imaging | November 10, 2017
To address the specific needs of medical imaging clinical engineering departments nationwide, Siemens Healthineers has...
HeartFlow's FFR-CT (FFRct) analysis software can create a virtual FFR to assess coronary artery disease.

HeartFlow's FFR-CT analysis software uses a computed tomography scan and supercomputing fluid dynamics software to create a noninvasive, virtual FFR map of the entire coronary artery tree to determine the flow-limiting severity of ant lesions. 

News | Cardiac Imaging | November 06, 2017
November 6, 2017 – The Centers for Medicare & Medicaid Services (CMS) has finalized a New Technology Ambulatory P
Philips Announces Findings of Patient Experience in Imaging Research
News | Cardiac Imaging | October 24, 2017
Philips recently announced the key findings of its research focused on the patient experience in diagnostic imaging...
Overlay Init